Filter articles using the following links

BIO International Convention, San Diego, CA (US)

GenSight Biologics reports long-term positive safety and visual acuity results at Week 96 in Phase I/II Study of GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

15ème Forum Santé Gilbert Dupont, Paris (France)

ISCAS 2017, Baltimore, Maryland (US)

GenSight Biologics to Present Data on GS010 and GS030 at the Annual Meeting of ARVO

2017 ARVO Annual Meeting, Baltimore, Maryland (US)

4th Annual Retinal Cell & Gene Therapy Innovation Summit, Baltimore (MD)

GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer

Deutsche Bank 42nd Annual Health Care Conference, Boston, MA (US)

GenSight Biologics Announces the Filing of its 2016 Registration Document